PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer: targeted pill plus chemo tested
Disease control OngoingThis study tests a new daily pill (narmafotinib) combined with standard chemotherapy (FOLFIRINOX) in about 67 people with pancreatic cancer that has spread. The goal is to find the safest and most effective dose. This is not a cure, but aims to better control the disease.
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Amplia Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 03:21 UTC
-
Can a common diabetes pill help pancreatic cancer patients manage blood sugar?
Disease control OngoingThis study looks at how safe and effective glipizide, a standard diabetes drug, is for lowering blood sugar in people with pancreatic cancer. About 29 adults with active pancreatic cancer and high blood sugar will take glipizide and have their glucose levels monitored. The goal i…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New cocktail of drugs takes on tough pancreatic cancer
Disease control OngoingThis early-phase trial tests whether adding two immune-boosting drugs (botensilimab and balstilimab) to a strong chemotherapy mix plus two oral medications (chloroquine and celecoxib) can help people with metastatic pancreatic cancer that hasn't been treated yet. The study includ…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New pill targets Cancer's 'Extra DNA' in desperate patients
Disease control OngoingThis early-phase study tests an experimental oral drug, BBI-355, in people with advanced solid tumors (like certain breast, ovarian, lung, and other cancers) that have extra copies of cancer-driving genes. The goal is to find a safe dose and see if BBI-355, alone or with other ta…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
New drug combo shows promise for Hard-to-Treat GI cancers
Disease control OngoingThis study is testing a combination of two drugs, pelareorep and atezolizumab, in people with advanced or metastatic gastrointestinal cancers like anal and pancreatic cancer. The goal is to see if the combination is safe and can shrink tumors or slow disease progression. About 12…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Enzyme pills aim to fight weight loss in advanced pancreatic cancer
Symptom relief OngoingThis study tests whether taking pancreatic enzyme pills (pancrelipase) can help people with metastatic pancreatic cancer maintain or gain weight. The study includes 17 participants who are starting chemotherapy. Researchers will compare two different dosing schedules and measure …
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 03:17 UTC